Natus Medical Incorporated (NASDAQ:BABY) insider James B. Hawkins purchased 4,000 shares of Natus Medical stock in a transaction on Thursday, June 15th. The shares were acquired at an average cost of $33.98 per share, for a total transaction of $135,920.00. Following the purchase, the insider now owns 578,023 shares in the company, valued at $19,641,221.54. The acquisition was disclosed in a document filed with the SEC, which is available through this link.
James B. Hawkins also recently made the following trade(s):
- On Wednesday, May 31st, James B. Hawkins purchased 6,000 shares of Natus Medical stock. The shares were acquired at an average cost of $33.81 per share, for a total transaction of $202,860.00.
Natus Medical Incorporated (BABY) traded up 1.30% during mid-day trading on Friday, hitting $35.00. The stock had a trading volume of 362,037 shares. The stock has a market cap of $1.14 billion, a PE ratio of 33.65 and a beta of 0.95. Natus Medical Incorporated has a one year low of $33.15 and a one year high of $44.39. The firm’s 50-day moving average is $34.68 and its 200 day moving average is $36.86.
Natus Medical (NASDAQ:BABY) last issued its earnings results on Wednesday, April 26th. The medical equipment provider reported $0.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.33 by $0.03. The company had revenue of $124.70 million for the quarter, compared to analyst estimates of $122.45 million. Natus Medical had a net margin of 8.17% and a return on equity of 12.70%. The company’s quarterly revenue was up 42.8% on a year-over-year basis. During the same period last year, the business earned $0.34 EPS. Equities research analysts expect that Natus Medical Incorporated will post $1.70 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Natus Medical Incorporated (BABY) Insider James B. Hawkins Buys 4,000 Shares” was published by sleekmoney and is the sole property of of sleekmoney. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://sleekmoney.com/natus-medical-incorporated-baby-insider-james-b-hawkins-buys-4000-shares/1916745.html.
A number of research analysts have weighed in on the company. Benchmark Co. reissued a “buy” rating and set a $48.00 price target (down previously from $55.00) on shares of Natus Medical in a research note on Monday, May 1st. Zacks Investment Research lowered Natus Medical from a “hold” rating to a “sell” rating in a research note on Friday, April 28th. Finally, TheStreet lowered Natus Medical from a “b” rating to a “c+” rating in a research note on Thursday, April 27th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the stock. Natus Medical has a consensus rating of “Hold” and an average target price of $45.00.
Several large investors have recently modified their holdings of BABY. Piedmont Investment Advisors LLC raised its stake in shares of Natus Medical by 142.8% in the first quarter. Piedmont Investment Advisors LLC now owns 41,032 shares of the medical equipment provider’s stock worth $1,611,000 after buying an additional 24,132 shares during the period. Lyon Street Capital LLC raised its stake in shares of Natus Medical by 65.6% in the first quarter. Lyon Street Capital LLC now owns 755,167 shares of the medical equipment provider’s stock worth $29,640,000 after buying an additional 299,151 shares during the period. AQR Capital Management LLC raised its stake in shares of Natus Medical by 3.4% in the first quarter. AQR Capital Management LLC now owns 46,162 shares of the medical equipment provider’s stock worth $1,811,000 after buying an additional 1,522 shares during the period. State Street Corp raised its stake in shares of Natus Medical by 8.5% in the first quarter. State Street Corp now owns 810,658 shares of the medical equipment provider’s stock worth $31,823,000 after buying an additional 63,493 shares during the period. Finally, Oppenheimer Asset Management Inc. bought a new stake in shares of Natus Medical during the first quarter worth about $309,000. 92.62% of the stock is owned by institutional investors.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/natus-medical-incorporated-baby-insider-james-b-hawkins-buys-4000-shares/1916745.html
Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.